Continued nationwide drug shortages and supply chain disruptions have prompted South Dakota Gov. Kristi Noem to call on the state department of health to make an expansion of the state's medical cache, according to a July 12 news release. 

Less than a week after Eisai secured a full approval for Leqembi — the first Alzheimer's drug to achieve full approval — the drugmaker's CEO announced his plan to retire by the end of July. 

CVS Health's pharmacy benefit manager, CVS Caremark, teamed up with GoodRx to broaden access to cheaper drug options, the organizations said July 12. 

System errors unexpectedly disrupted CVS Caremark's prescription processing July 11, leaving patients frustrated and some without access to medication, The Wall Street Journal reported July 10. 

There's a national shortage of dimercaprol, the main therapy for lead poisoning, The Wall Street Journal reported July 11. About four months ago, the country's only domestic supplier of the product closed its doors.

More than $8.4 billion in expected annual contract savings for the hospital safety-net is at risk, according to a July 11 report from 340B Health.

ADC Therapeutics is voluntarily pausing enrollment in a phase 2 study evaluating two drugs for lymphoma after seven patients died and five experienced worsening health during treatment. 

The Biden administration released a plan July 11 to clamp down on xylazine-fentanyl mixtures, a drug combination that it labeled an emerging threat in April and that has mystified clinicians.

When an illness paralyzed Renee Tyree, PharmD, at 19 years old, she was told she wouldn't become a doctor after she became a wheelchair user. 

The American Society of Health-System Pharmacists has honored six hospitals with its certificate of excellence in medication use safety and pharmacy practice.